Home phototherapy requires a hospital-organized service, not simply a portable light. Before buying a home-use fleet, establish clinical selection, access to bilirubin testing, family support and a route back to hospital.

Portability does not demonstrate suitability for home use. The devices shown here are catalogue options for enquiry; their home-use authorization and suitability have not been established. Obtain model-specific documentation before considering them for that setting.

Start with the support commitment

Assign a clinical lead and define how families can obtain timely advice during the treatment period. Confirm the practical journey for testing and review, including transport and availability outside routine clinic hours. The service should not depend on a parent interpreting bilirubin results independently.

Require a demonstrated handover

Train caregivers using the actual approved configuration and written instructions they understand. Ask them to show setup, explain whom to contact and describe what they would do if treatment cannot be delivered as instructed. Record the demonstration rather than treating delivery of a leaflet as completed training.

Plan return, cleaning and failure response

A home fleet needs tracking by device and accessory set, documented cleaning between households and a replacement route when a unit fails. Separate this logistics plan from the clinical decision to readmit. Verify that the family can decline home treatment without losing access to appropriate care.

Procurement comparison

Decision before ordering

Evaluate the service with a small, clinically governed implementation before expanding a fleet. Review missed tests, support calls, equipment problems and returns to hospital as operational signals; do not present a device as universally suitable for home treatment.